Nevakar Incis A Specialty Pharmaceutical Company Based In Bridgewaternew Jerseyfounded In 2015The Company Focuses On Developing And Commercializing Innovative Products In The Ophthalmic And Injectable Sectors To Meet Unmet Medical Needs And Enhance Patient Care Utilizing The 505 B2Regulatory Pathwaynevakar Efficiently Develops New Formulations And Indications For Existing Drugsits Product Portfolio Features Several Differentiated Sterile Injectable Productsdeveloped In Partnership With Companies Like Endo International Plcwhich Aids In Seeking Fda Approval And Distributionadditionallynevakar Launched Vyluma In 2021Dedicated To Creating Treatments For Ophthalmic Diseases Such As Myopia Nevakar Has Successfully Raised Significant Funding To Support Its Product Pipelinetotaling $81 09 Millionthe Company Has Also Filed Numerous Patentsshowcasing Its Commitment To Innovation In Pharmaceuticals
No conferences found for this company.
| Company Name | Nevakar Llc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
